Cargando…
Transketolase regulates sensitivity to APR-246 in p53-null cells independently of oxidative stress modulation
The prevalence and dire implications of mutations in the tumour suppressor, p53, highlight its appeal as a chemotherapeutic target. We recently showed that impairing cellular antioxidant systems via inhibition of SLC7A11, a component of the system x(c)(−) cystine-glutamate antiporter, enhances sensi...
Autores principales: | Milne, Julia V., Zhang, Bonnie Z., Fujihara, Kenji M., Dawar, Swati, Phillips, Wayne A., Clemons, Nicholas J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904805/ https://www.ncbi.nlm.nih.gov/pubmed/33627789 http://dx.doi.org/10.1038/s41598-021-83979-3 |
Ejemplares similares
-
A thiol‐bound drug reservoir enhances APR‐246‐induced mutant p53 tumor cell death
por: Ceder, Sophia, et al.
Publicado: (2020) -
APR-246 increases tumor antigenicity independent of p53
por: Michels, Judith, et al.
Publicado: (2023) -
Mutant p53-reactivating compound APR-246 synergizes with asparaginase in inducing growth suppression in acute lymphoblastic leukemia cells
por: Ceder, Sophia, et al.
Publicado: (2021) -
Correction: Mutant p53-reactivating compound APR-246 synergizes with asparaginase in inducing growth suppression in acute lymphoblastic leukemia cells
por: Ceder, Sophia, et al.
Publicado: (2022) -
APR-246 Enhances Colorectal Cancer Sensitivity to Radiotherapy
por: Xie, Xuqin, et al.
Publicado: (2023)